Content on PharmTech.com this week ranged from fundamentals on the use of digital pathology in drug development, discussions on the use of AI in pharma, and regulatory actions impacting the industry.
|Articles|January 2, 2015
- Pharmaceutical Technology-01-02-2015
- Volume 39
- Issue 1
Shimadzu ICP Optical Emission Spectrometer Decreases Costs
Shimadzu’s ICPE-9800 series of simultaneous ICP optical emission spectrometers feature an eco mode to reduce operating costs by suppressing argon gas flow rate and power consumption by 50%. Used for analytical service and quality control laboratories, the series features two models: the ICPE-9810 with axial view plasma observation in a direction coaxial to the plasma, and ICPE-9820 with axial view and radial view plasma observation in the perpendicular direction.
The series is designed with Shimadzu’s vertically oriented mini-torch system to reduce argon gas consumption, power, memory effects, and rinse time. Even when using 99.95% pure argon gas, and not the typical gas of 99.99% or purer, the systems are able to ensure performance while reducing operating costs. ICPEsolution software allows users to save spectral data, add separate elements and wavelengths after measuring, and check or re-analyze data.
Shimadzu
Article DetailsPharmaceutical Technology
Vol. No. 1
Page: 14
Articles in this issue
over 11 years ago
Value-Based Healthcare in the: United Kingdomover 11 years ago
Mitigating Risk for Single-Use Assemblies in Sterile Fillingover 11 years ago
Building a Barrier in Solid-Dosage Drug Packagingover 11 years ago
Using Tocophersolan for Drug Deliveryover 11 years ago
Industry Expert Q&A with Fred Miesowiczover 11 years ago
Innovative Excipients in Solid-Dosage Manufacturingover 11 years ago
Great Expectations from New European Commissionover 11 years ago
Analyzing Protein Aggregation in Biopharmaceuticalsover 11 years ago
Ross Charging Hopper Increases Efficiencyover 11 years ago
Standards Organizations UpdateRelated to this article
This article discusses risk-based lifecycle governance, system implementation considerations, and the progression of batch record control from paper-based to fully electronic systems.
Ronald Piervincenzi, USP, explains why manufacturers should act now and how benchmarking could reward reliable generic drug suppliers.
The FDA approves Lilly's once-weekly insulin efsitora for type 2 diabetes, raising Fc-fusion manufacturing, high-concentration pen, and capacity questions.
Florin Muraru, Gourav Pandey, and Richard Jaenisch explain where human sign-off belongs as multi-agent AI and document-parsing models reach GxP.
In this episode of Ask the Expert, Siegfried Schmitt, PhD, vice president, Technical at Parexel, and Susan J. Schniepp, distinguished fellow at Nelson Labs, discuss how companies should approach post-approval changes to their CMC regulatory filings.
The EC has approved AstraZeneca's Trixeo Aerosphere as the first single-inhaler triple-combination therapy for asthma in the EU, based on phase e data showing improved lung function and fewer severe exacerbations in patients uncontrolled on standard ICS/LABA treatment.
In this episode of Pharma Fundamentals, Dr. Aleksandra Zuraw, senior veterinary pathologist at Charles River, provides an introduction to the use of digital pathology in drug development.
Trending on Pharmaceutical Technology
1
Risk-Based Life Cycle Management of Master Production and Control Records to Strengthen Data Integrity and GMP Inspection Readiness Part 2: Practical Considerations for CGMP Documentation Systems
2
The FDA Finalizes Rule Recognizing Non-Animal Testing Methods, Building on Year-Long Reduction Push
3
PharmTech’s Weekly Roundup—September 25, 2026
4
CPHI Milan: USP Benchmarks Reshape Procurement Incentives
5